| DC67218 |
Moderna Lipid compound 182
|
Moderna Lipid compound 182 is an novel ionizable amine lipid used for mRNA delivery from Moderna patent WO2017049245A2 |
| DC67217 |
Moderna Lipid compound 46
|
Moderna Lipid compound 46 is an novel ionizable amine lipid used for mRNA delivery from Moderna patent WO2017049245A2 |
| DC67215 |
Acuitas Lipid III-7
|
Acuitas Lipid III-7 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent US 10,166,298 B2. |
| DC67214 |
Acuitas II-12
|
Acuitas II-12 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent WO2016176330A1 |
| DC67213 |
Acuitas II-10
|
Acuitas II-10 is an novel ionizable amine lipid used for mRNA delivery from Acuitas Therapeutics patent WO2016176330A1 |
| DC60711 |
CL15F 9-5
|
CL15F 9-5 is a piperidine-based ionizable lipid for mRNA delivery and improves the long-term storage stability of mRNA/LNPs at refrigeration temperature as a liquid formulation. CL15F 9-5 LNPs exhibits significantly stronger antigen-specific cellular responses than mice immunized with SM-102 and ALC-0315 LNPs. |
